ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd. - Current Ratioverified

IPA

Price:

$1.62

Market Cap:

$89.53M

ImmunoPrecise Antibodies Ltd. (IPA) is a global biotechnology firm that, through its subsidiaries, focuses on the development and production of antibodies, alongside offering a broad spectrum of related scientific services. Its operational footprint spans across the United States, Canada, Europe, Australia, and other international territories. For the research community, IPA delivers a diverse portfolio of products, including various types of antibodies, enzymes, enzyme activity assays, specialized animal products for arthritis studies, proteins (such as deiminated proteins), organoid growth factors, and hybridoma reagents. As a comprehensive Contract Research Organization (CRO), IPA provide...[Read more]

Industry

Biotechnology

IPO Date

2002-01-07

Stock Exchange

NASDAQ

Ticker

IPA

The Current Ratio as of July 2026 (TTM) for ImmunoPrecise Antibodies Ltd. (IPA) is 2.80

According to ImmunoPrecise Antibodies Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.80. This represents a change of -12.64% compared to the average of 3.21 of the last 4 quarters.

ImmunoPrecise Antibodies Ltd. (IPA) Historical Current Ratio (quarterly & annually)

How has IPA Current Ratio performed in the past?

The mean historical Current Ratio of ImmunoPrecise Antibodies Ltd. over the last ten years is 2.86. The current 2.80 Current Ratio has changed 9.70% with respect to the historical average. Over the past ten years (40 quarters), IPA's Current Ratio was at its highest in in the April 2021 quarter at 8.05. The Current Ratio was at its lowest in in the June 2016 quarter at 0.09.

Quarterly (TTM)
Annual

Average

2.86

Median

2.44

Minimum

0.97

Maximum

8.05

ImmunoPrecise Antibodies Ltd. (IPA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ImmunoPrecise Antibodies Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 728.71%

Maximum Annual Current Ratio = 8.05

Minimum Annual Increase = -71.55%

Minimum Annual Current Ratio = 0.97

Quarterly (TTM)
Annual
YearCurrent RatioChange
20262.8034.64%
20252.0847.18%
20241.41-50.15%
20232.84-29.66%
20224.03-49.88%
20218.05728.71%
20200.97-29.19%
20191.3722.82%
20181.12-71.55%
20173.9224.24%

ImmunoPrecise Antibodies Ltd. (IPA) Average Current Ratio

How has IPA Current Ratio performed in the past?

The current Current Ratio of ImmunoPrecise Antibodies Ltd. (IPA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

2.10

5-year avg

2.63

10-year avg

2.86

ImmunoPrecise Antibodies Ltd. (IPA) Current Ratio vs. Peers

How is IPA’s Current Ratio compared to its peers?

ImmunoPrecise Antibodies Ltd.’s Current Ratio is less than IGM Biosciences, Inc. (17.66), less than Jade Biosciences, Inc. (14.29), less than Quince Therapeutics, Inc. (2.92), less than Landos Biopharma, Inc. (6.09), less than Surface Oncology, Inc. (7.94), greater than Heat Biologics, Inc. (0.00), less than Berkeley Lights, Inc. (3.89), less than Reneo Pharmaceuticals, Inc. (13.78), less than Achilles Therapeutics plc (8.57), less than Miromatrix Medical Inc. (5.52),

Build a custom stock screener for ImmunoPrecise Antibodies Ltd. (IPA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmunoPrecise Antibodies Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmunoPrecise Antibodies Ltd. (IPA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmunoPrecise Antibodies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is ImmunoPrecise Antibodies Ltd.'s Current Ratio?

How is the Current Ratio calculated for ImmunoPrecise Antibodies Ltd. (IPA)?

What is the highest Current Ratio for ImmunoPrecise Antibodies Ltd. (IPA)?

What is the 3-year average Current Ratio for ImmunoPrecise Antibodies Ltd. (IPA)?

What is the 5-year average Current Ratio for ImmunoPrecise Antibodies Ltd. (IPA)?

How does the current Current Ratio for ImmunoPrecise Antibodies Ltd. (IPA) compare to its historical average?